ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: The resulting hybrid gene produces BCR‐ABL1, a chimeric oncoprotein with constitutive tyrosine kinase activity that promotes CML by aberrantly phosphorylating target proteins.